30

THE FUTURE OF PHARMACY

INTERNATIONAL PHARMACY JOURNAL

DPWFSBHF/FXDBTFTXFSFGPVOEGPS%. GPS)15 BOEGPSCPUI%.BOE)15BMMUIFDBTFTXFSFSFGFSSFEUP t h e i r p r i m a r y c a r e uni t s (PCU) for f ur t h e r t r e a t m e nt . 4 The PCU sat i s f a c t i o n is hig h a n d s o m e PCUs pa i d t h e p h a r m a c i e s f r o m t h e i r ow n b u d g e t t o co nt i n u e t hi s a c t i v i t y. 5

The CPA play e d a big ro l e in 2 0 0 8 ; t h e Ass o c i a t i o n w a s o ut - s o u r c e d by t h e NHSO to p e r f o r m h o m e h e a l t h c a r e fo r 7 0 0 un - c o nt r o l l e d p a t i e nt s in B a n g k o k . Non - c o m p l i a n c e of m e d i c a - t i o n w a s fo u n d t h e m a j o r c a u s e of t h e p r o b l e m s ; p h a r m a c i s t s DPVMEJNQSPWFUIFJSBEIFSFODFCZBGUFSUIFUIJSEWJTJU 6 This pr o j e c t h a s b e e n co nt i n u e d sin c e t h e n , a n d e x p a n d e d t o ot h e r p r o v i n c e s – Ubon - r a t c h a t h a n i , S ur a t - t h a n i , a n d Phuke t .

In lat e 2 0 1 1 , a c t i v i t i e s co n c e r n i n g in - p h a r m a c y m e d i c a t i o n us e r e v i e w a n d co g n i t i v e s e r v i c e s we r e gr a nt e d . The pr o j e c t is not fin a l i z e d y e t , b ut t h e m e d i c a t i o n us e r e v i e w a c t i v i t y s e e m s p r o m i s i n g t h a t it wa s a p p l i e d in ot h e r t hr e e p r o v i n c e s in 2 0 1 2 .

All ac t i v i t i e s co n d u c t e d sh o w e d t h e i r ef f e c t i v e n e s s , cu s t o m - e r s a t i s f a c t i o n a n d ef fi c i e n c y. The NHSO fun di n g , t ot a l i n g , is wo r t h m o r e t h a n 1 mill i o n US $. Nonet h e l e s s t h e a c t i v i t i e s h a v e b e e n co n d u c t e d o n a nn u a l p r o j e c t b a s i s ; it is n ot a n it e m i z e d b u d g e t un d e r t h e NHSO per he a d c a p i t a t i o n . The sit u a t i o n is dif fi c u l t t o co n v i n c e m o r e p h a r m a c i e s t o jo i n t h e p r o g r a m fo r fe a r of un c e r t a i nt y a n d t h e i r in v e s t m e nt , t h u s , w a s wo r t h l e s s . On th e co nt r a r y, t h e co m m u n i t y p h a r m a c y a c t i v i t i e s a r e un d e r v a r i o u s c h a l l e n g e s su c h a s a b i l i t y t o e x p a n d a c r o s s t h e co u nt r y, co m m u n i t y p h a r m a c i s t co m p e - t e n c y, p h a r m a c i s t ’ s et h i c s et c .

Creating the future of pharmacy in Thailand: the CPA roles The cr o s s r o a d s sit u a t i o n d e m a n d s m o r e p r o a c t i v e r o l e s f r o m CPA to g a in t r u s t f r o m b ot h p o li c y m a k e r s a s we ll a s ma k i n g p h a r m a c i s t s ’ co m p e t e n c y e v i d e nt t o t h e p ub l i c . Howe v e r, ge n e r a l l y in Tha il a n d m o s t of ch a n g e s a r e ini t i a t e d by p ub l i c s e c t o r whi l e p r of e s s i o n a l s e c t o r lik e t h e CPA ha s re l a t i v e l y l e s s ro l e s . More o v e r, t h e is s u e s of a c c r e d i t e d p h a r m a c y a n d int e g r a t i n g a c c r e d i t e d p h a r m a c y in h e a l t h in s u r a n c e s c h e m e h a v e n ot b e e n a c c e p t e d wh o l e h e a r t e d l y by CPA Bo a r d m e m b e r s sin c e t h e b e g i n n i n g of t h e ro a d m a p im p l e m e nt a - t i o n . Cons e q u e nt l y, t h e CPA posi t i o n is a mb i v a l e nt a n d t h e p r o g r e s s in a ll dim e n s i o n s r e l a t i n g t o a c c r e d i t e d p h a r m a c y is sl o w. Nonet h e l e s s , t h e t o p i c of a c c r e d i t e d p h a r m a c y a d v a n c e m e nt h a s b e e n o n t h e CPA age n d a sin c e 2 0 0 7. Ther e a r e a num b e r of a c t i v i t i e s c a r r i e d o ut by CPA whic h m a y b e gr o u p e d int o a r e a s of n o r m a l i z a t i o n of p h a r m a c y p r a c t i c e s a n d s t r e n g t h e n i n g p h a r m a c y co m p e t e n c y.

At t h e b e g i n n i n g , m o s t of wo r k s fo c u s e d o n s e t t i n g co m m o n v i e w s a m o n g CPA memb e r s . The “ S e l f - d e v e l o p m e nt Manua l o n GPP in Commun i t y Pha r m a c y ” w a s p ub l i s h e d in 2 0 0 9 a n d di s t r i b u t e d t o co m m u n i t y p h a r m a c i e s t o p r o v i d e inf o r m a - t i o n a n d e x a m p l e s of wh a t a c c r e d i t e d p h a r m a c y is . This is e x p e c t e d t o cr e a t e c l e a r e r un d e r s t a n d i n g s a n d s t a n d a r d i z e p h a r m a c i s t s ’ p e r f o r m a n c e s . In 2 01 0 , CPA de v e l o p e d a s e t of Q u a l i t y Indi c a t o r s (QI) in or d e r t h a t p h a r m a c i e s c a n id e nt i f y t h e i r we a k p o i nt s in co m p a r i s o n t o t h e GPP st a n d a r d s . It is a l s o e x p e c t e d t h a t CPA coul d s e t t r a i n i n g p r o g r a m s r e l e v a nt t o t h o s e we a k p o i nt s . The QI ha s b e e n un d e r im p r o v e m e nt wit h s o m e inp u t s f r o m Ms Eeva Ter a s a l m i (The Finla n d Pha r m a c y Ass o c i a t i o n) a n d t h e Pha r m a c y Gui l d of Aust r a l i a .

TABLE 1: PROJECTS OF PHARMACY SERVICES GRANTED BY NHSO SINCE 2004

A CTIV ITIES AREAS CO N DUCTED YEAR STARTED

Fill pr e s c r i p t i o n One pr o v i n c e 2 0 0 4 – pr e s e nt (Nako r n - r a t c h s i m a )

Refill p r e s c r i p t i o n One pr o v i n c e 2 0 0 4 ( dis c o nt i n u e d ) (S a m u t - p r a k a r n) S c r e e n i n g a n d r i s k a n a l y s i s (DM,HPT) 4 pr o v i n c e s 2 0 0 6 – pr e s e nt (K h o n Ke a n , Nako r n - r a t c h s i m a , Maha - s a r a k a m a n d B a n g k o k )

Home ph a r m a c e u t i c a l c a r e 4 pr o v i n c e s 2 0 0 8 – p r e s e nt ( B a n g k o k ) (B a n g k o k , Ubon - r a t c h a t h a n i , 2 01 2 – Ubon - r a t c h a t h a n i , Sur a t - t h a n i a n d Phuke t ) Sur a t - t h a n i , Phuke t

Medic a t i o n us e r e v i e w 5 pr o v i n c e s 2 0 1 1 - p r e s e nt (Maha - s a r a k a m ,Roi - e t ) ( in - p h a r m a c y s e r v i c e s ) (Maha - s a r a k a m , Roi - e t , B a n g k o k , 2 01 2 – B a n g k o k , S u r a t - t h a n i a n d Phuke t Sur a t - t h a n i a n dPhuke t ) Cogni t i v e s e r v i c e s 2 pr o v i n c e s 2 0 1 1 - p r e s e nt (S m o k i n g ce s s a t i o n , we i g ht l o s s) (Maha - s a r a k a m a n d Roi - e t )